Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Goudsmit

Showing results (161-170 of 424) with videos related to

Pageof 43
Sort By:
AIDS (London, England)|September 1, 1990
Correlation of HIV core antigen, antibody and immune complex levels in sera of HIV-infected individualsE Ujhelyi, J Lange, J Goudsmit, et al.
Vox Sanguinis|January 1, 1987
Detection of early anti-p24 HIV responses in EIA- and immunoblot-negative individuals. Implications for confirmatory testingJ G Huisman, I N Winkel, P N Lelie, et al.
AIDS (London, England)|October 1, 1988
Antibodies to soluble CD4 in HIV-1-infected individualsC Thiriart, J Goudsmit, P Schellekens, et al.
Genitourinary Medicine|June 1, 1990
HIV-1 P24 antigenaemia does not predict time of survival in AIDS patientsJ W Mulder, P Krijnen, J Goudsmit, et al.
Antiviral Therapy|August 1, 1996
Decline of HIV-1 RNA in cerebrospinal fluid during zidovudine treatmentP Portegies, S A Danner, R H Enting, et al.
AIDS Research and Human Retroviruses|March 1, 1994
Frequent and early HIV-1MN neutralizing capacity in sera from Dutch HIV-1 seroconverters is related to antibody reactivity to peptides from the gp120 V3 domainG Zwart, N K Back, C Ramautarsing, et al.
Prosthetics and Orthotics International|June 3, 2004
An automatic hinge system for leg orthosesJ S Rietman, J Goudsmit, D Meulemans, et al.
Journal of Virology|September 1, 1992
Evolution of the V3 envelope domain in proviral sequences and isolates of human immunodeficiency virus type 1 during transition of the viral biological phenotypeC L Kuiken, J J de Jong, E Baan, et al.
Genitourinary Medicine|June 1, 1991
Serum beta 2-microglobulin levels in asymptomatic HIV-1-infected subjects during long-term zidovudine treatmentJ W Mulder, P Krijnen, R A Coutinho, et al.
The Journal of General Virology|April 1, 1996
Consistent risk group-associated differences in human immunodeficiency virus type 1 vpr, vpu and V3 sequences despite independent evolutionC L Kuiken, M T Cornelissen, F Zorgdrager, et al.
Pageof 43

Showing results (161-170 of 424) with videos related to

Sort By:
Pageof 43
AIDS (London, England)|September 1, 1990
Correlation of HIV core antigen, antibody and immune complex levels in sera of HIV-infected individualsE Ujhelyi, J Lange, J Goudsmit, et al.
Vox Sanguinis|January 1, 1987
Detection of early anti-p24 HIV responses in EIA- and immunoblot-negative individuals. Implications for confirmatory testingJ G Huisman, I N Winkel, P N Lelie, et al.
AIDS (London, England)|October 1, 1988
Antibodies to soluble CD4 in HIV-1-infected individualsC Thiriart, J Goudsmit, P Schellekens, et al.
Genitourinary Medicine|June 1, 1990
HIV-1 P24 antigenaemia does not predict time of survival in AIDS patientsJ W Mulder, P Krijnen, J Goudsmit, et al.
Antiviral Therapy|August 1, 1996
Decline of HIV-1 RNA in cerebrospinal fluid during zidovudine treatmentP Portegies, S A Danner, R H Enting, et al.
AIDS Research and Human Retroviruses|March 1, 1994
Frequent and early HIV-1MN neutralizing capacity in sera from Dutch HIV-1 seroconverters is related to antibody reactivity to peptides from the gp120 V3 domainG Zwart, N K Back, C Ramautarsing, et al.
Prosthetics and Orthotics International|June 3, 2004
An automatic hinge system for leg orthosesJ S Rietman, J Goudsmit, D Meulemans, et al.
Journal of Virology|September 1, 1992
Evolution of the V3 envelope domain in proviral sequences and isolates of human immunodeficiency virus type 1 during transition of the viral biological phenotypeC L Kuiken, J J de Jong, E Baan, et al.
Genitourinary Medicine|June 1, 1991
Serum beta 2-microglobulin levels in asymptomatic HIV-1-infected subjects during long-term zidovudine treatmentJ W Mulder, P Krijnen, R A Coutinho, et al.
The Journal of General Virology|April 1, 1996
Consistent risk group-associated differences in human immunodeficiency virus type 1 vpr, vpu and V3 sequences despite independent evolutionC L Kuiken, M T Cornelissen, F Zorgdrager, et al.
Pageof 43